NOAH Compendium

Printed from NOAH Compendium (http://www.noahcompendium.co.uk). (c) Copyright NOAH Compendium 2020. All Rights Reserved.
Date: Monday, July 6, 2020 1:36

Release 5.54
Colombovac PMV Suspension for subcutaneous injection
 
Species: Pigeons
Therapeutic indication: Immunological veterinary medical products: For pigeons
Active ingredient: Vaccine Antigens
Product:Colombovac® PMV
Product index: Colombovac PMV
Withdrawal notes: Pigeons: Zero days
Presentation
Inactivated Newcastle Disease Virus, strain La Sota. At least 19.9 AU* per 0.2 ml dose. Also contains 1 mg carbomer 934 P as adjuvant and 20 μg thiomersal as preservative.
*AU: Antigen Unit
Uses
For active immunisation of pigeons to prevent mortality and clinical signs due to infection with paramyxovirus serotype 1 infection.
Onset of immunity: One month after inoculation
Duration of immunity: 12 months.
Dosage and administration
The vial has to be swirled several times before use.
Administration
One dose (0.2ml) per pigeon.
The vaccine has to be administered by subcutaneous injection dorsally in the neck region (in the direction of the back).
Dosage regimen:
1. Racing pigeons: All birds in the loft should be given one vaccination annually not less than 14 days before the beginning of the racing season. Young birds may be vaccinated with Colombovac PMV from 3 weeks of age when a single injection will provide immunity for 1 year. Following vaccination avoid contact with birds from other lofts for at least 14 days.
All adult birds in the loft should be given a single booster vaccination annually. Where the annual booster vaccination may interfere with the training or racing programme, it may be brought forward prior to the commencement of each racing season.
2. Show pigeons: All birds on the premises should be given one vaccination annually not less than 14 days before the beginning of the show season. Young birds may be vaccinated with Colombovac PMV from 3 weeks of age when a single injection will provide immunity for 1 year. Following vaccination, avoid contact with birds from other sources for at least 14 days.
All adult birds on the premises should be given a single booster vaccination annually.
Contra-indications, warnings, etc
Do not use in unhealthy pigeons.
Do not vaccinate during the last 2 weeks prior to mating.
Do not use in birds in lay or within 4 weeks before the onset of the laying period.
Vaccination is safe in breeding birds provided they are vaccinated before the start of breeding.
No information is available on the safety and efficacy of this vaccine when used with any other veterinary medicinal product. A decision to use this vaccine before or after any other veterinary medicinal product therefore needs to be made on a case by case basis.
Do not mix with any other veterinary medicinal product.
Adverse reactions
A transient swelling at the injection site of up to approximately 1 cm in diameter may occur very commonly, which may last up to 4 weeks or more. Swellings normally tend to disappear without treatment. In cases of adverse reactions not disappearing spontaneously the veterinary surgeon should be contacted.
The frequency of adverse reactions is defined using the following convention:
- very common (more than 1 in 10 animals displaying adverse reactions during the course of one treatment)
- common (more than 1 but less than 10 animals in 100 animals)
- uncommon (more than 1 but less than 10 animals in 1,000 animals)
- rare (more than 1 but less than 10 animals in 10,000 animals)
- very rare (less than 1 animal in 10,000 animals, including isolated reports).
An overdose did not result in adverse reactions other than those mentioned above.
Special warnings
Not for intramuscular injection: Intramuscular injection causes severe adverse reactions.
Maternally-derived antibody (MDA) can interfere with the development of active immunity. Where it is likely that recent field infection or vaccination of the parent flock has stimulated a high antibody titre and consequently a high level of MDA, the timing of the vaccination programme should be planned accordingly.
In cases of hypersensitivity reactions treat immediately with glucocorticoid intravenously or adrenaline intramuscularly.
The incubation period for pigeon paramyxovirosis may be a few days to several weeks. However, after infection with the wild virus, pigeons excrete the virus from the eye and in the droppings within 3-4 days. This means that infected birds can be a danger to others some days before their own symptoms appear. Excretion of wild virus from the infected bird continues for up to 6 weeks. This information is important since, in addition to direct bird to bird contact at competitions and shows, the disease can be spread by indirect means such as hands, overalls, caps, boots and contaminated objects such as baskets and trucks.
An owner should forbid visits to the loft by anyone in contact with unvaccinated pigeons and new birds (either purchased or lent for mating) should not be brought in unless vaccinated at least 14 days previously.
Withdrawal period
Zero days.
User warnings
In case of accidental self-injection, seek medical advice immediately and show the package leaflet or the label to the physician.
Pharmaceutical precautions
Store and transport refrigerated (2°C to 8°C). Do not freeze. Protect from light.
Use entire contents of vial once opened.
Do not use after the expiry date stated on the label.
For animal treatment only.
Keep out of the sight and reach of children.
Legal category
Legal category: POM-VPS
Packaging quantities
1 x 50 doses (10 ml)
1 x 100 doses (20 ml)
Not all pack sizes may be marketed.
Further information
Disposal
Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal products should be disposed of in accordance with local requirements.
Marketing Authorisation Number
Vm 42058/4020
Significant changes
GTIN
GTIN description:50 dose (10 ml):
GTIN:08714015011006
GTIN description:100 dose (20 ml):
GTIN:08714015010993